Matthew Klein
Chief Executive Officer at PTC THERAPEUTICS, INC.
Net worth: 2 M $ as of 29/06/2024
Matthew Klein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Director/Board Member | 15/04/2020 | - |
| Independent Dir/Board Member | 15/04/2020 | - | |
| PTC THERAPEUTICS, INC. | Director/Board Member | 21/03/2023 | - |
| Chief Executive Officer | 21/03/2023 | - | |
| President | 21/03/2023 | - | |
| Chief Operating Officer | 06/01/2022 | 21/03/2023 | |
| Corporate Officer/Principal | 30/09/2019 | 06/01/2022 | |
| Stanford University | Corporate Officer/Principal | - | - |
| PTC Therapeutics International Ltd. | Director/Board Member | - | - |
Career history of Matthew Klein
Former positions of Matthew Klein
| Companies | Position | Start | End |
|---|---|---|---|
BioElectron Technology Corp.
 BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Director/Board Member | 31/12/2017 | 31/12/2019 |
| Chief Executive Officer | 31/12/2017 | 31/12/2018 | |
| Chief Tech/Sci/R&D Officer | 31/12/2011 | 31/12/2018 | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Edison Pharmaceuticals, Inc.
 Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Matthew Klein
| University of Pennsylvania | Undergraduate Degree |
| Yale University | Doctorate Degree |
| UW School of Public Health | Graduate Degree |
Statistics
International
| United States | 10 |
| Ireland | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| CLEARPOINT NEURO, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Health Technology |
| PTC Therapeutics International Ltd. | |
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Commercial Services |
- Stock Market
- Insiders
- Matthew Klein
- Experience
